Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride 58602-0703
Product NDC
58602-0703- Manufacturer
- Aurohealth Llc
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 8, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA212409
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cetirizine Hydrochloride | 5 mg/1 |
| Pseudoephedrine Hydrochloride | 120 mg/1 |
Drug Class
Adrenergic alpha-Agonists [MoA]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(4)
12 BLISTER PACK in 1 CARTON (58602-703-09) / 2 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
12 BLISTER PACK in 1 CARTON (58602-703-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
2 BLISTER PACK in 1 CARTON (58602-703-75) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
4 BLISTER PACK in 1 CARTON (58602-703-76) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
External Resources